Prestige Consumer Healthcare Inc. (PBH)
NYSE: PBH · Real-Time Price · USD
64.99
+0.39 (0.60%)
Aug 15, 2025, 4:00 PM - Market closed
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2013 - 2020 |
North American OTC Healthcare | 960.01M | Log In | Log In | Log In | Log In | Upgrade |
North American OTC Healthcare Growth | -0.44% | Log In | Log In | Log In | Log In | Upgrade |
International OTC Healthcare | 177.75M | Log In | Log In | Log In | Log In | Upgrade |
International OTC Healthcare Growth | 6.59% | Log In | Log In | Log In | Log In | Upgrade |
Analgesics | 117.70M | Log In | Log In | Log In | Log In | Upgrade |
Analgesics Growth | 0.52% | Log In | Log In | Log In | Log In | Upgrade |
Cough & Cold | 106.21M | Log In | Log In | Log In | Log In | Upgrade |
Cough & Cold Growth | -7.74% | Log In | Log In | Log In | Log In | Upgrade |
Women's Health | 236.83M | Log In | Log In | Log In | Log In | Upgrade |
Women's Health Growth | 1.67% | Log In | Log In | Log In | Log In | Upgrade |
Gastrointestinal | 255.94M | Log In | Log In | Log In | Log In | Upgrade |
Gastrointestinal Growth | 10.20% | Log In | Log In | Log In | Log In | Upgrade |
Eye & Ear Care | 183.32M | Log In | Log In | Log In | Log In | Upgrade |
Eye & Ear Care Growth | -9.00% | Log In | Log In | Log In | Log In | Upgrade |
Dermatologicals | 128.95M | Log In | Log In | Log In | Log In | Upgrade |
Dermatologicals Growth | -0.59% | Log In | Log In | Log In | Log In | Upgrade |
Oral Care | 95.03M | Log In | Log In | Log In | Log In | Upgrade |
Oral Care Growth | 3.93% | Log In | Log In | Log In | Log In | Upgrade |
Other OTC | 13.78M | Log In | Log In | Log In | Log In | Upgrade |
Other OTC Growth | 9.69% | Log In | Log In | Log In | Log In | Upgrade |
Gross Income by Product
Fiscal year is April - March.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2013 - 2020 |
Other | 8.88M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 2.52% | Log In | Log In | Log In | Log In | Upgrade |
North American OTC Healthcare Gross Margin | 531.14M | Log In | Log In | Log In | Log In | Upgrade |
North American OTC Healthcare Gross Margin Growth | -5.02% | Log In | Log In | Log In | Log In | Upgrade |
International OTC Healthcare Gross Margin | 103.32M | Log In | Log In | Log In | Log In | Upgrade |
International OTC Healthcare Gross Margin Growth | 3.46% | Log In | Log In | Log In | Log In | Upgrade |
Other | 8.88M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 2.52% | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is April - March.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2013 - 2020 |
North American OTC Healthcare Contribution Margin | 401.71M | Log In | Log In | Log In | Log In | Upgrade |
North American OTC Healthcare Contribution Margin Growth | -1.68% | Log In | Log In | Log In | Log In | Upgrade |
International OTC Healthcare Contribution Margin | 77.03M | Log In | Log In | Log In | Log In | Upgrade |
International OTC Healthcare Contribution Margin Growth | 2.16% | Log In | Log In | Log In | Log In | Upgrade |